Joseph Zeballos-Roig Feb 27, 2020
President Donald Trump with Health and Human Services
Secretary Alex Azar. Reuters
The Trump administration reversed itself on Thursday and said a coronavirus vaccine would be affordable for the American public after it generated a storm of criticism over the drug's potential high cost.
Health and Human Services Secretary Alex Azar said he would guarantee public access to a vaccine.
Only a day earlier, he declined to do so and cited the need for financial involvement from the private sector.
The development of a vaccine that successfully treats COVID-19 is still far off — at least a year in the best case scenario.
The Trump administration reversed itself on Thursday and said a coronavirus vaccine would be affordable for Americans amid a storm of criticism over its possible high cost.
Health and Human Services Secretary Alex Azar told lawmakers during a congressional hearing that he would guarantee public access to a vaccine that treats COVID-19, the disease that the coronavirus causes.
"I have directed my teams that if we do any joint venture with a private enterprise, that we're cofunding the research and development program, that we would ensure there's access to the fruits of that, whether vaccine or therapeutics," Azar said.
The remarks come a day after Azar triggered massive blowback when he didn't promise a coronavirus vaccine would be financially accessible to most Americans.
"We would want to ensure that we work to make it affordable, but we can't control that price because we need the private sector to invest," Azar told lawmakers at another congressional hearing. "Price controls won't get us there."
Democrats immediately hit back. House Speaker Nancy Pelosi said at a press conference on Thursday: "This would be a vaccine that is developed with the taxpayer dollars … and we think that should be available to everyone, not dependent on Big Pharma."
The development of a vaccine that successfully treats COVID-19 is still far off — at least a year in the best case scenario, given the rounds of rigorous testing involved on animals and humans.
Anthony Fauci, a top official at the National Institute of Health, said on Wednesday it would take between 12 and 18 months to create one and placed the focus on public-health measures instead to curb the virus' spread in the US.
The Trump administration is seeking a multibillion-dollar emergency spending package to fight the coronavirus, which has spread to over 47 countries from its point of origin in China. There are at least 60 confirmed cases in the US so far, most of which developed abroad.
At least $1 billion of the federal funding would be directed toward the creation of a vaccine, The Washington Post reported.
The Trump administration reversed course after saying the coronavirus vaccine might not be affordable for all Americans
Eliza Relman Feb 26, 2020
President Donald Trump with Health and Human Services
Secretary Alex Azar. Reuters
Health and Human Services Secretary Alex Azar on Wednesday declined to promise that a coronavirus vaccine would be affordable for all Americans, sparking outrage from Democrats.
"We would want to ensure that we work to make it affordable, but we can't control that price because we need the private sector to invest," Azar told members of Congress.
On Monday, the president asked Congress for $2.5 billion in funding to fight the coronavirus — including more than $1 billion designated for vaccine development.
Democratic leadership criticized the president's request as "anemic" and inadequate.
The administration reversed itself Thursday and said a coronavirus vaccine would be affordable for the American public, after generating a storm of criticism over its potential high cost
Health and Human Services Secretary Alex Azar on Wednesday declined to promise that a coronavirus vaccine would be affordable for all Americans.
"We would want to ensure that we work to make it affordable, but we can't control that price because we need the private sector to invest," Azar told members of Congress during a hearing concerning the coronavirus outbreak and the administration's budget request. "Price controls won't get us there."
—Michael McAuliff (@mmcauliff) February 26, 2020
—NowThis (@nowthisnews) February 26, 2020
Democrats and other critics quickly condemned Azar.
"Secretary Azar is refusing to promise that a Coronavirus vaccine will be affordable to every American. Kick them out of office," Sen. Brian Schatz, a Hawaii Democrat, tweeted Wednesday evening.
The progressive group Center for American Progress tweeted, "This is a global health crisis, and everyone should have the right to medication that will help protect them from this virus."
While government and private researchers around the world are working quickly to develop a vaccine for the virus, it is estimated that any vaccine is still several months away. The best preventive measure is regular thorough handwashing.
House Speaker Nancy Pelosi slammed Azar's comments on Thursday and said any vaccine developed with taxpayer dollars would need to be made affordable.
After significant backlash, the administration reversed course Thursday and said any future COVID-19 vaccine would be made affordable.
"I have directed my teams that if we do any joint venture with a private enterprise, that we're co-funding the research-and-development program, that we would ensure there's access to the fruits of that, whether vaccine or therapeutics," Azar said.
On Monday, the president asked Congress for $2.5 billion in funding to fight the coronavirus — including more than $1 billion designated for vaccine development. Democratic leadership criticized the president's request as "anemic" and inadequate.
As of Wednesday, the US had confirmed 60 cases of the novel coronavirus that originated in the central Chinese city of Wuhan.
COVID-19, the disease caused by the virus, has killed nearly 2,800 people and infected more than 81,000 since December. The vast majority of cases and deaths have been in China.
The US Centers for Disease Control and Prevention has confirmed cases in six states: Arizona, California, Illinois, Massachusetts, Washington, and Wisconsin. Officials have recorded two cases of human-to-human transmission among family members.
Aria Bendix, Rosie Perper, and Lauren Frias contributed to this report.
The Trump administration reversed itself on Thursday and said a coronavirus vaccine would be affordable for the American public after it generated a storm of criticism over the drug's potential high cost.
Health and Human Services Secretary Alex Azar said he would guarantee public access to a vaccine.
Only a day earlier, he declined to do so and cited the need for financial involvement from the private sector.
The development of a vaccine that successfully treats COVID-19 is still far off — at least a year in the best case scenario.
The Trump administration reversed itself on Thursday and said a coronavirus vaccine would be affordable for Americans amid a storm of criticism over its possible high cost.
Health and Human Services Secretary Alex Azar told lawmakers during a congressional hearing that he would guarantee public access to a vaccine that treats COVID-19, the disease that the coronavirus causes.
"I have directed my teams that if we do any joint venture with a private enterprise, that we're cofunding the research and development program, that we would ensure there's access to the fruits of that, whether vaccine or therapeutics," Azar said.
The remarks come a day after Azar triggered massive blowback when he didn't promise a coronavirus vaccine would be financially accessible to most Americans.
"We would want to ensure that we work to make it affordable, but we can't control that price because we need the private sector to invest," Azar told lawmakers at another congressional hearing. "Price controls won't get us there."
Democrats immediately hit back. House Speaker Nancy Pelosi said at a press conference on Thursday: "This would be a vaccine that is developed with the taxpayer dollars … and we think that should be available to everyone, not dependent on Big Pharma."
The development of a vaccine that successfully treats COVID-19 is still far off — at least a year in the best case scenario, given the rounds of rigorous testing involved on animals and humans.
Anthony Fauci, a top official at the National Institute of Health, said on Wednesday it would take between 12 and 18 months to create one and placed the focus on public-health measures instead to curb the virus' spread in the US.
The Trump administration is seeking a multibillion-dollar emergency spending package to fight the coronavirus, which has spread to over 47 countries from its point of origin in China. There are at least 60 confirmed cases in the US so far, most of which developed abroad.
At least $1 billion of the federal funding would be directed toward the creation of a vaccine, The Washington Post reported.
The Trump administration reversed course after saying the coronavirus vaccine might not be affordable for all Americans
Eliza Relman Feb 26, 2020
President Donald Trump with Health and Human Services
Secretary Alex Azar. Reuters
Health and Human Services Secretary Alex Azar on Wednesday declined to promise that a coronavirus vaccine would be affordable for all Americans, sparking outrage from Democrats.
"We would want to ensure that we work to make it affordable, but we can't control that price because we need the private sector to invest," Azar told members of Congress.
On Monday, the president asked Congress for $2.5 billion in funding to fight the coronavirus — including more than $1 billion designated for vaccine development.
Democratic leadership criticized the president's request as "anemic" and inadequate.
The administration reversed itself Thursday and said a coronavirus vaccine would be affordable for the American public, after generating a storm of criticism over its potential high cost
Health and Human Services Secretary Alex Azar on Wednesday declined to promise that a coronavirus vaccine would be affordable for all Americans.
"We would want to ensure that we work to make it affordable, but we can't control that price because we need the private sector to invest," Azar told members of Congress during a hearing concerning the coronavirus outbreak and the administration's budget request. "Price controls won't get us there."
—Michael McAuliff (@mmcauliff) February 26, 2020
—NowThis (@nowthisnews) February 26, 2020
Democrats and other critics quickly condemned Azar.
"Secretary Azar is refusing to promise that a Coronavirus vaccine will be affordable to every American. Kick them out of office," Sen. Brian Schatz, a Hawaii Democrat, tweeted Wednesday evening.
The progressive group Center for American Progress tweeted, "This is a global health crisis, and everyone should have the right to medication that will help protect them from this virus."
While government and private researchers around the world are working quickly to develop a vaccine for the virus, it is estimated that any vaccine is still several months away. The best preventive measure is regular thorough handwashing.
House Speaker Nancy Pelosi slammed Azar's comments on Thursday and said any vaccine developed with taxpayer dollars would need to be made affordable.
After significant backlash, the administration reversed course Thursday and said any future COVID-19 vaccine would be made affordable.
"I have directed my teams that if we do any joint venture with a private enterprise, that we're co-funding the research-and-development program, that we would ensure there's access to the fruits of that, whether vaccine or therapeutics," Azar said.
On Monday, the president asked Congress for $2.5 billion in funding to fight the coronavirus — including more than $1 billion designated for vaccine development. Democratic leadership criticized the president's request as "anemic" and inadequate.
As of Wednesday, the US had confirmed 60 cases of the novel coronavirus that originated in the central Chinese city of Wuhan.
COVID-19, the disease caused by the virus, has killed nearly 2,800 people and infected more than 81,000 since December. The vast majority of cases and deaths have been in China.
The US Centers for Disease Control and Prevention has confirmed cases in six states: Arizona, California, Illinois, Massachusetts, Washington, and Wisconsin. Officials have recorded two cases of human-to-human transmission among family members.
Aria Bendix, Rosie Perper, and Lauren Frias contributed to this report.
No comments:
Post a Comment